Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of traditional Chinese medicines and botanical products in China. It offers chemical medicines, Chinese patent medicines, eye health products, nutritional supplements, health supplies, healthy daily necessities and food products, and other personal care products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.

Zhejiang CONBA Pharmaceutical Co.,Ltd.

康恩贝集团 is involved in the healthcare sector, focusing on the development and production of healthcare products.

康恩贝集团

Zhejiang Conba Pharmaceutical Co., Ltd. | 264 followers on LinkedIn. Zhejiang Conba Pharma is a pharmaceuticals company based out of HANGZHOU, ZHJ, China.

Zhejiang Conba Pharmaceutical Co., Ltd. - R&D Managers

Jeremy Jin

Metric
Company Name	Zhejiang CONBA Pharmaceutical Co.,Ltd.
Symbol	600.57K
MSH ID	COM:CONBAGROUP
Market	STOCKS
Sector	Healthcare
Industry	Drug Manufacturers - General
Country	CN
Stage
Employee Count	8.41K
Website	conbagroup.com
LinkedIn	zhejiang-conba-pharmaceutical-co-ltd-
Founders

Metric
Market Cap	1.58B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	926.07M
Revenue (LTM)
Revenue (NTM)
Gross Profit	541.55M
EBITDA	160.09M
Operating Income	116.27M
Net Income	81.37M
EPS	0.03
Diluted EPS	0.03
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.59
Operating Profit Margin	0.15
EBITDA Margin	0.17
Net Profit Margin	0.11
Return on Equity	0.11
Return on Assets	0.07
Return on Capital Employed	0.12

6005

COM:CONBAGROUP

康恩贝集团

Last Close

4.59

25/11 07:00

Market Cap

11.47B

Beta: -

Volume Today

27.47M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	14.87
P/B Ratio	1.57
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.14
EV Multiple	18.21

Metric
Days Sales Outstanding	112.18
Days Payables Outstanding	111.50
Days Inventory Outstanding	175.22
Operating Cycle	290.02
Cash Conversion Cycle	187.33
Asset Turnover	0.62

Metric
Operating Cash Flow	123.60M
Free Cash Flow	94.84M
Cash Flow to Debt	1.64
Operating Cash Flow/Sales	0.15
Free Cash Flow Yield	0.07

Metric
Cash & Equivalents	353.49M
Accounts Receivable	-37.34M
Inventory	183.34M
Goodwill	25.41M
Debt to Capitalization	0.13
Debt to Assets	0.05
Current Ratio	1.94
Quick Ratio	1.53

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.03
SG&A to Revenue	0.02